tirzepatide glp 1 side effects Comparative safety and of semaglutide and tirzepatide: Implications for clinical decision-making in obesity management Bumps and humps in the

Euglycemic diabetic ketoacidosis (DKA), a side effect of sodium-glucose cotransporter-2 (SGLT2) inhibitors, is a triad of high metabolic anion gap acidosis, raised serum and urine ketones, and serum glucose <250 mg/dl

To help answer these and many others, I recently launched The GLP-1 Dietitian Hub, a growing community and newsletter dedicated to empowering dietitians with practical, up to date resources, relevant research, and a space to connect so we can navigate GLP-1 therapy with confidence

Arvind Venkat, D-Pittsburgh, and Rep

Learn why it's crucial to avoid using GLP-1 medications past their expiration date